All In MedTech

Device Trial Radar · NCT02921568

Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes

Last checked: Nov 20, 2026Latest source record: Mar 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

20

Planned (sponsor's estimate)

Start

Sep 2016

Primary completion

Dec 2017

Sponsor

Lead sponsor
Optos, PLCNot on our public-company list
Sponsor type
Industry
Collaborators
Optos, Inc.
First posted
Oct 3, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to evaluate and compare in-tissue performance of OCT scans on the new Optos P200TE, versus the predicate Optos Spectral OCT/SLO device.

Conditions

  • Retinal Disease
  • Glaucoma

Interventions

  • P200TEDevice

    Optical Coherence Tomography and Scanning Laser Ophthalmoscope device.

  • Spectral OCT/SLODevice

    Optical Coherence Tomography and Scanning Laser Ophthalmoscope device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. retinal thicknessTime frame: completion of the study, up to 5 years
  2. Retinal Nerve Fibre Layer ThicknessTime frame: completion of the study, up to 5 years
  3. Optic Nerve Head TopographyTime frame: completion of the study, up to 5 years

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Medical Center Ophthalmology Associates

    San Antonio, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.